Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Skeletal muscle dysfunction in COPD: miRNAs, myokines and exercise.
ERJ open research·2026
Same author
A cross sectional study of the autonomic function at different recovery phases in SARS-CoV-2 patients without orthostatic symptoms.
Scientific reports·2026
Same author
Effectiveness of exercise training in people with non-cystic fibrosis bronchiectasis with and without COPD.
Frontiers in rehabilitation sciences·2026
End stage chronic obstructive pulmonary disease.
Nicolino Ambrosino1, Marco Gherardi, Nicoletta Carpenè
1Respiratory Intensive Care and Pulmonary Diseases Unit, Cardio-Thoracic Department, University Hospital Pisa, Cisanello 56127 Pisa, Italy. n.ambrosino@ao-pisa.toscana.it
Pneumonologia I Alergologia Polska
|May 23, 2009
Summary
Severe chronic obstructive pulmonary disease (COPD) management requires better guidelines. While smoking cessation and oxygen therapy improve survival, non-invasive ventilation shows promise for exacerbations and end-stage symptom relief.
More Related Videos
Area of Science:
- Pulmonary Medicine
- Respiratory Care
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality, yet current guidelines offer limited recommendations for severe stages (GOLD III-IV) with chronic respiratory failure.
- Survival in COPD is primarily improved by smoking cessation and long-term oxygen therapy (LTOT).
Purpose of the Study:
- To review current evidence and recommendations for managing severe COPD, focusing on survival, symptom relief, and quality of life.
- To evaluate the role of non-invasive positive pressure ventilation (NPPV) and other interventions in severe COPD.
Main Methods:
- Systematic review of prospective, randomized controlled studies, and meta-analyses.
- Analysis of evidence for interventions including smoking cessation, LTOT, NPPV, surgical options, pulmonary rehabilitation, and palliative care.
Main Results:
- NPPV has strong evidence for acute exacerbations of COPD and as an alternative to invasive ventilation for symptom relief in end-stage disease.
- Surgical interventions and lung transplantation benefit a small patient subset but can improve quality of life when combined with pulmonary rehabilitation.
- Palliative therapies, including bronchodilators, opiates, and supplemental oxygen, are crucial for symptom management (dyspnea, breathlessness) in advanced COPD.
Conclusions:
- Management of severe COPD necessitates a shift towards palliative care and symptom relief alongside life-prolonging strategies.
- Integrated care, including psychological and social support, is vital for improving the well-being of frail elderly COPD patients and their families.